Search Results - "Naraoka, Hitoshi"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Metabolic Profiling to Identify Potential Serum Biomarkers for Gastric Ulceration Induced by Nonsteroid Anti-Inflammatory Drugs by Takeuchi, Kenichiro, Ohishi, Maki, Ota, Sana, Suzumura, Kenichi, Naraoka, Hitoshi, Ohata, Takeji, Seki, Jiro, Miyamae, Youichi, Honma, Masashi, Soga, Tomoyoshi

    Published in Journal of proteome research (01-03-2013)
    “…Nonsteroid anti-inflammatory drugs (NSAIDs) are among the most frequently prescribed drugs currently available. The most frequently reported serious side…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Progression process and safety assessment adaptation of endometrial lesions in ENU-induced 2-stage uterine carcinogenicity in a Tg-rasH2 mouse model by Kuroda, Hiroyuki, Kinomoto, Toshiko, Ogawa, Shuji, Kawabe, Mayumi, Suguro, Mayuko, Naraoka, Hitoshi, Takamatsu, Kazuhiko, Oishi, Yuji

    Published in Journal of Toxicologic Pathology (01-01-2018)
    “…Although acotiamide hydrochloride hydrate (acotiamide-HH) has not been reported to have genotoxic findings in any of the genotoxicity studies or…”
    Get full text
    Journal Article
  5. 5

    Metabolomic analysis of the effects of omeprazole and famotidine on aspirin-induced gastric injury by Takeuchi, Kenichiro, Ohishi, Maki, Endo, Keiko, Suzumura, Kenichi, Naraoka, Hitoshi, Ohata, Takeji, Seki, Jiro, Miyamae, Yoichi, Honma, Masashi, Soga, Tomoyoshi

    Published in Metabolomics (01-10-2014)
    “…Gastric mucosal ulceration and gastric hemorrhage are frequently associated with treatment by non-steroid anti-inflammatory drugs (NSAIDs); however, no…”
    Get full text
    Journal Article
  6. 6

    Pharma challenges to adoption of microphysiological system in drug research and development, especially safety assessment by Naraoka, Hitoshi

    Published in Nihon yakurigaku zasshi (2023)
    “…In the environment surrounding the pharma industries (1) declining productivity in research and development in pharma industries, (2) spreading of 3Rs in…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Evaluation of H-FABP as a marker of ongoing myocardial damage using hGH transgenic mice by Naraoka, Hitoshi, Ito, Kyoko, Suzuki, Michie, Naito, Kunihiko, Tojo, Hideaki

    Published in Clinica chimica acta (01-11-2005)
    “…There are few heart-specific and highly sensitive biomarkers of cardiac disorders in experimental animals. To evaluate ongoing myocardial damage in…”
    Get full text
    Journal Article
  9. 9

    Analysis of Gender Difference of Cardiac Risk Biomarkers Using hGH-Transgenic Mice by NARAOKA, Hitoshi, ITO, Kyoko, SUZUKI, Michie, NAITO, Kunihiko, TOJO, Hideaki

    Published in Experimental Animals (01-01-2006)
    “…We investigated gender difference in the effects of chronic exposure to human growth hormone (hGH) on cardiac risk biomarkers using transgenic mice with…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Role of biomarkers in toxicity treatment "metabonomics" as a new biomarker discovery method by Naraoka, Hitoshi, Suzumura, Ken-ichi, Takeuchi, Ken-ichiro, Sasayama, Takeshi

    “…For the treatment of clinical toxicity, investigations to determine the offending substance and rapid treatment are required. Particularly in the case of drug…”
    Get more information
    Journal Article
  12. 12

    Investigation of Mechanisms for MK-801-Induced Neurotoxicity Utilizing Metabolomic Approach by Kuroda, Kanae, Suzumura, Kenichi, Shirakawa, Takafumi, Hiraishi, Tomoko, Nakahara, Yutaka, Fushiki, Hiroshi, Honda, Sokichi, Naraoka, Hitoshi, Miyoshi, Sosuke, Aoki, Yoshinobu

    Published in Toxicological sciences (01-08-2015)
    “…Single treatment of rats with the noncompetitive N-methyl-D-aspartate receptor antagonist MK-801 induces neuronal cell degeneration and death in the…”
    Get full text
    Journal Article
  13. 13

    Consideration for the validation of clinical laboratory methods in nonclinical fields by Minomo, Hirofumi, Inoue, Yoshimi, Iwachido, Takako, Oota, Hiromi, Otabe, Koji, Kubono, Katsuo, Kondo, Satoshi, Sasaki, Daisuke, Suzuki, Yusuke, Nakamura, Yuta, Naraoka, Hitoshi, Higashiyama, Masumi, Fujisawa, Nozomi, Honda, Kumi, Matsumoto, Tadao, Yasui, Hideki, Saito, Yoshiro, Toyota, Naoto

    Published in Bioanalysis (01-11-2022)
    “…In new drug development, cells or animals are treated with the selected candidate compound to confirm its efficacy and safety in nonclinical studies. Clinical…”
    Get full text
    Journal Article
  14. 14

    [18F]FDG-PET as an imaging biomarker to NMDA receptor antagonist-induced neurotoxicity by Shirakawa, Takafumi, Mitsuoka, Keisuke, Kuroda, Kanae, Miyoshi, Sosuke, Shiraki, Katsuhisa, Naraoka, Hitoshi, Noda, Akihiro, Fujikawa, Akihiko, Fujiwara, Michio

    Published in Toxicological sciences (01-05-2013)
    “…Positron emission tomography (PET) is an effective tool for noninvasive examination of the body and provides a range of functional information. PET imaging…”
    Get full text
    Journal Article
  15. 15

    Hydroxyproline, a Serum Biomarker Candidate for Gastric Ulcer in Rats: A Comparison Study of Metabolic Analysis of Gastric Ulcer Models Induced by Ethanol, Stress, and Aspirin by Kenichiro Takeuchi, Maki Ohishi, Keiko Endo, Kenichi Suzumura, Hitoshi Naraoka, Takeji Ohata, Jiro Seki, Yoichi Miyamae, Masashi Honma, Tomoyoshi Soga

    Published in Biomarker insights (01-01-2014)
    “…Gastrointestinal symptoms are a common manifestation of adverse drug effects. Non-steroid anti-inflammatory drugs (NSAIDs) are widely prescribed drugs that…”
    Get full text
    Journal Article